Home » Topics » Regulatory

Regulatory
RSS

Miltefosine evaluated clinically for the oral treatment of visceral leishmaniasis

Dec. 22, 1998

No Comments

FDA approves first Lyme disease vaccine

Dec. 22, 1998

No Comments

FDA approves abacavir for treatment of HIV-1 infection

Dec. 21, 1998

No Comments

Expanded indications, new formulation of Lamictal now available in U.S.

Dec. 21, 1998

No Comments

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

No Comments

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

No Comments

Eisai launches new formulation of antiarrhythmic drug in Japan

Dec. 16, 1998

No Comments

FDA approves expanded indication for CytoGam

Dec. 14, 1998

No Comments

Philippines is the first market for lamivudine as anti-HBV agent

Dec. 14, 1998

No Comments

Schering-Plough files NDA for next-generation corticosteroid

Dec. 14, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Miltefosine evaluated clinically for the oral treatment of visceral leishmaniasis

FDA approves first Lyme disease vaccine

FDA approves abacavir for treatment of HIV-1 infection

Expanded indications, new formulation of Lamictal now available in U.S.

Chirocaine receives first regulatory approval in Sweden

Orphan Medical files NDS for Busulfex Injection in Canada

Eisai launches new formulation of antiarrhythmic drug in Japan

FDA approves expanded indication for CytoGam

Philippines is the first market for lamivudine as anti-HBV agent

Schering-Plough files NDA for next-generation corticosteroid

Today's news in brief

Today's news in brief

Regulatory actions for Oct. 31, 2024

Nanocube’s nanorobots to revolutionize cancer diagnosis, treatment

Cureverse, Angelini ink $360M deal for oral Alzheimer’s drug

Regulatory RSS

Regulatory
RSS